CD274 and pneumonitis: According to an analysis from the World Health Organization (WHO) pharmacovigilance database, colitis, pneumonitis, hepatitis, myocarditis, myositis, nephritis, myasthenia gravis, encephalitis and meningitis are among the most common fatal toxic effects associated with PD-(L)1 inhibitors [16].